[LABP] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
12-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 26.48%
YoY- -50.49%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
Revenue 0 0 0 0 0 -
PBT -8,897 -6,034 -14,864 -9,818 -5,796 11.30%
Tax 0 -445 -89 64 198 -
NP -8,897 -5,589 -14,775 -9,818 -5,796 11.30%
Tax Rate - - - - - -
Total Cost 8,897 5,589 14,775 9,818 5,796 11.30%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 CAGR
EPS -1.43 -0.86 -3.67 -3.80 -1.78 -5.32%
EPS Diluted -1.43 -0.86 -3.67 -3.80 -1.78 -5.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.